California latest to sue drug companies over insulin prices
By ADAM BEAM
Associated Press
SACRAMENTO, Calif. (AP) — California says it will sue the companies that make and promote much of the nation’s insulin. Democratic Attorney General Rob Bonta announced the lawsuit Thursday. The lawsuit accuses insulin manufacturers Eli Lilli, Novo Nordisk and Sanofi of keeping prices too high. It also blames pharmacy benefit managers CVS Caremark, Express Scripts and Optum Rx. California is one of many states that have sued these companies in recent years. California is also considering making its own generic version of insulin to try and drive down the price. People with certain types of diabetes need insulin to survive.